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Human cells contain several homologs of the bacterial
mutl, gene required for mismatch repair, including a
gene on chromosome 7 designated hPMS2. We have
identified an endometrial carcinoma cell line, HEC-I-A,
that has a C ---... T mutation in hPMS2 that generates a
nonsense codon and yields a protein truncated at the C
terminus. No wild-type gene or gene product was de-
tected. The missing amino acids in hPMS2 are highly
conserved among PMS homologs, suggesting that they
may be critical for function. In support of this, extracts
of HEC-I-A cells are defective in repairing a variety of
mismatched substrates. Moreover, di-, trio, and tet-
ranucleotide repeated sequences are highly unstable in
single cell clones ofBEC-I-A cells, and HEC-I-A cells are
resistant to killing by N-methyl-N' -nitro-N-nitrosogua-
nidine. The results provide strong experimental support
for the involvement of the hPMS2 gene product in mis-
match repair in human cells and support the concept
that a defective hPMS2 gene may lead to predisposition
to certain forms of cancer.
Instability of simple repetitive sequences is common in tu-
mor DNAs from hereditary nonpolyposis colorectal carcinoma
(HNPCC)1 kindreds and from individuals with sporadic can-
cers that are commonly associated with HNPCC (1-6). The
majority of HNPCC kindreds have germline alterations in hu-
man homologs of the bacterial mismatch repair genes mutS
and mutL (7-13). Inactivation of the human hMSH2 and
hMLHl genes in cells of these individuals is thought to result
in a mutator phenotype that is required for subsequent tumor
progression (for review, see Refs. 14 and 15).
Supporting a role for the hMLHl and hMSH2 gene products
in mismatch repair is the finding that extracts of colon and
endometrial tumor cell lines with a mutation in hMSH2 or
hMLHl are defective in mismatch repair (16, 17). These cells
also exhibit microsatellite instability, and several such lines
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have elevated mutation rates in endogenous genes (Refs. 16-21
and references therein). Cell lines defective in mismatch bind-
ing and/or repair have been shown to be resistant to killing by
treatment with otherwise lethal doses of DNA alkylating
agents (Refs. 20-22 and reviewed in Ref. 23). Moreover, the
introduction of chromosome 3 containing a wild-type copy of
the hMLHl gene to a hMLHl-defective line restores DNA
mismatch repair activity, reduces microsatellite instability,
and increases sensitivity to MNNG (21). These data strongly
imply that both hMSH2 and hMLHl function in mismatch
repair.
Eukaryotic cells contain several genes that share sequence
homology with the bacterial mutL gene. In yeast, these are
designated yMLHl (24) and yPMSl (25, 26). Interaction of the
yMLHI and yPMSl proteins has been demonstrated by protein
affinity chromatography (27). Moreover, ypmsl mutants have
elevated mutation rates and are epistatic for this phenotype
with yeast ymlhl mutants (24), supporting a role for yPMSl in
mismatch repair. Additional genes exist in yeast that, when
mutated, yield phenotypes similar to ypmsl mutants (Ref. 28
and references therein). Human cells likewise contain several
mutL homologs. In addition to the hMLHl gene on chromosome
3 (2, 8), there are mutL homologs designated hPMSl located on
chromosome 2 (10) and hPMS2 located on chromosome 7p22
(10, 29). The latter is closely related by sequence homology to
the yPMSl gene. The hPMS2 has been described as a member
of a subfamily that includes at least two related genes located
on chromosome 7q (29). Recently, Horii et al. (30) have isolated
additional PMS-like sequences and have suggested that hPMS
genes constitute a family containing at least 11 members.
Given the large number of hPMS sequences, what is the
evidence that any of these function in mismatch repair? A role
for both hPMSl and hPMS2 in cancer, and by extrapolation, in
mismatch repair, has been inferred from a mutation found in a
single HNPCC family for each gene (29). However, since
HNPCC individuals are at risk for developing alterations in
many genes, it is possible that these single examples of hPMSl
and hPMS2 mutations are not causally related to disease pro-
gression or to the presumed mismatch repair defect. A func-
tional role for hPMS2 in mismatch repair is also suggested by
the observation that a mismatch repair-defective extract made
from a cell line containing a mutant hMLHl gene is comple-
mented by a purified fraction containing hMLHl and a second
protein that is either hPMS2 or a closely related gene product
(31). As noted by the authors, the identity of this second protein
is uncertain because the complementing protein is 110 kDa
while the deduced amino acid sequence of the hPMS2 gene
product predicts a 95,808-kDa protein and because one puta-
tive peptide sequence derived from the 110-kDa protein was
not found in the predicted hPMS2 polypeptide.
Thus, the role of hPMS2 in mismatch repair and in cancer is
not yet as clearly established as for hMSH2 and hMLH1, where
a wealth of information is available on many mutations in
HNPCC families, in tumor DNA, and in tumor cell lines. Be-
yond the report by Nicolaides et al. (29), no additional HNPCC
kindreds, tumor DNAs, or tumor cell lines have been reported
to contain mutations of any hPMS gene. Establishing a role in
mismatch repair (or a lack thereof) for hPMS genes would be
facilitated by identifying and characterizing tumor cell lines
containing mutations in these homologs. Toward this end, we
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FIG. 1. Mutation detection in HEC-I -A cells. a, prot ein truncation
test of RT-PCR produ cts of codons 415-862 of hPMS2. The prot ein s
produced by in vitro transcription and translati on were separa te d on a
15% SDS-polyacrylami de gel. Sizes of prestaincd molecu lar weight
standa rds a re indicated to th e left . Lane I is th e protein produced from
norm al ut erine tissue . Lan e 2 is th e protein from HE C-I-A cells . b,
sequence of RT-PCR products . Sequ ence 1 is from HE C-I-A cells , dem-
onstrating th e C to T change in th e first position of codon 802 of hPMS2
(marked by an asterisk ). Sequ ence 2 is from the norm al human uteru s
RT-PCR product and is the wild-type hPMS2 seque nce.
RESULTS
HEC-l -A Cells Contain a hPMS2 Gene Mutation-We exam-
ined a variety of cell lin es derived from endometria l tumors (5),
the most common HN PCC-assoc iated non-colon tumor ty pe, for
mutations in the four genes reported to have alte rations in
HNPCC kind reds, Among th e approac hes we use to screen for
mutations is a protein t ru ncation assay (12), in which tumor
cell line RNA for a specific gen e seq uence is converted by
RT-PCR to cDNA. This DNA is t ra nscribed an d translated in
vitro wit h r35S]methionine to label the protein products, which
are th en reso lved by SDS-polyacrylamide gel elect rophoresis
and detected by autoradiography . The procedure rapidly de-
tects shorter protein products resulting from mutations such as
premature termination codons , frames hift s, delet ions, or aber-
ran t splicing. We screened a pan el of endometrial tumors and
tumor cell lines for mu tat ions usin g primers designed to yie ld
PCR products spa nning eithe r codons 1- 472 or codons 415-
862, respectively, of the hPMS2 gene (29). The produ ct of the
latter fragment that was amplified from nor ma l endometrial
t issue generated the expecte d protein of - 50 kDa (Fig. la, lane
1). Alth ough this sa me result was obtained with several tumor
cell lines (including KLE cells, see below), we found one cell
line, designated HEC-1-A, that yielded a hPMS2 polypeptide
that was slightly shorter than wild typ e (Fig. l a , lane 2). No
produc t of wild-ty pe size was obse rve d, sugge sting a reduction
to homozygosity for this alteration at the level of RNA expres-
sion. Parall el ana lyses of the othe r hal f of the gene and of the
hMSH2, hMLH1 , and hPMSl genes revealed no detectable
truncations of any of these genes in HEC -1-A cells (da ta not
shown ).
To determine the exact nature of the mutation in hPMS2, the
seq uence of the C-te rminal end of the gene was det ermined
from the PCR product that was used to generate the truncated
protein . A single C to T mutation was found at nucl eotide 2428
in codon 802 (Fig. 1b), creating a TGA termination codon that
predicts a pro tein t runcated by 61 amino acids. Thi s result is
consistent wit h the mobility shift seen in Fig. 1. No ba nd
indicative of the wild-ty pe nu cleot ide was observed at thi s
position on the sequencing gel. To confirm the absence of a
wild-type gene sequence, an independen t RT-PCR am plifica-
t ion was perform ed , and the resulti ng fragment was cloned and
sequenced. Ten of 10 clones contained the expected C to T
transition, and no wild-type clone was observed. To establish
that the observed mu ta tion was in hPMS2 an d not in a closely
rela ted PMS gene, we seq uenced 325 nucleotides of the gene,
corresponding to amino acid residues 753-861. Except for the
substitution at codon 802, the seq uence was ident ical to the
describ e here a mutation in th e hPMS2 gene in a hu man
endometria l carcinoma cell line (HEC-1-A) that yields a trun-
cated gene product but no detectab le wild -type hPMS2 protein .
We the n show th at it ha s th e prop er ti es predicted of a cell lin e
defecti ve in mismatch repa ir .
EXPERIMENTAL PROCEDURES
Cell Lin es-Human endometria l carcinoma cell lines HE C-I -A and
KLE were from the Ameri can Type Culture Collect ion. TK6 cells were
from P. Modri ch (Duke Univers ity ).
S ingle Cell Clone A nalysis of Microsatellite lnstability-Single cell
clones of HEC-I-A and KLE cells were mad e from a limiting dilution of
a clona l popul ati on of cells . DNA suita ble for PCR was prepared from
cells represe nting 18-25 doublings by a l -h digest ion at 56 °C in 100 J.Ll
of 1 x PCR buffer (see below) with out MgCl2 an d containing 100 ug/ml
proteinase K. The DNA prepar a tion was heat ed a t 95 °C to inactivat e
th e protein ase K before amplificat ion. DNAs were amplified by th e
polym erase cha in reacti on usin g oligonucleotides specific for severa l
repetiti ve seque nces . Primer s were from Research Gen etic s (Huntsville,
AL), and referen ces can be obtai ned from th e Jo hn s Hopkin s Un iver sity
genome data base (or, for vWFa , see Ref. 32). Each PCR (10 J.L1) con-
sisted of 50 mxt KCI, 10 mxt Tris-H Cl (pH 8.3), 1.5 m xi MgCI2 , 200 J.L ~I of
each deoxynucleotide triphosph at e, 1 J.L~ I of each prim er, 1 J.LI of DNA,
and 1 un it of Ampli t aq polym erase (Roche Molecular Syst ems, Ala-
meda, CAl. One prim er was end-labeled wit h [y_33PIATP and T4
polyn ucleotid e kinase prior to addit ion to th e reaction. PCR was per-
form ed for 35 cycles consisti ng of 20 s each at 94, 55, and 72 "C.
Following amplification, th e reaction was diluted 1:1 in a denaturing
loadi ng buffer of 98% formam ide, 10 mxt EDTA (pH 8.0), 0.02 % brom-
phenol blu e, 0.02% xylene cya nol FF and denatured at 95 °C for 3 min.
One-fift h of the den atured product was subjecte d to electrophores is for
3 h at 90 watts in a 6% polyacrylam ide gel containing 8.3 M urea an d
30% forma mide. Following electrophoresis gels were covered in a single
layer of myla r (Arnbis Sys te ms, San Diego, CAl, dri ed, and exposed to
x-ray film.
An aly sis of hPMS2 by Protein Truncation Test and DNA Sequenc-
ing-Tota l RNA was prepar ed from cell lines usin g the single ste p
procedure described by Chomczyns ki and Sacchi (33). First st ra nd
cDNA was prepared as described previously (34) and used as tem plate
for am plificatio n of hPMS2 in two fragments spa nning codons 1- 472
and codons 415- 863, usin g oligonucleotides containing T7 RNA polym-
erase sites as describ ed (12). A portion of each amplified product (5 J.L1)
serv ed as a templ ate for coupled t ranscr ipti on and tran slation in lO-J.Ll
reactions usin g th e TNTn l sys te m (Prornega, Madi son, WI) that incor-
porat es ['"Slmethionine to label the protein product. The reactions were
diluted 1:5 in SDS loading buffer and denatured at 97 °C for 5 min, and
4 J.Ll was loaded onto 15% SDS gels. The re mai nder of th e PCR product
DNA was gel-purified and seque nced on both strands , using Sequenase
v2.0. The prim ers used wer e PMS2 -2282 (TTGTTATCGATGAAAAT-
GCTC) and PMS2-2463 (GTCCCAATCATCACCGACTTC). Upon iden -
tification of the mu tat ion (see below), a second amplifica tion was per-
form ed, the frag ment was cloned, and clones were seque nced to confirm
the mutat ion. The hPMS2 gene seque nce was det ermined for codons
753- 860.
Mismatch Repair Assay-Cell-free ext rac ts and mism atched sub-
st ra tes were prepar ed as describ ed (35). Substrates contained the indi-
cate d mism atch and a nick in th e (-)-strand at position - 264, wher e
position +1 is the first tran scr ibed nucl eotid e of the LacZa gen e. Repair
reactions (25 J.L1) contained 30 mxi Hepes; 7 mxt MgCI2 ; 200 J.L~I each
CTP, GTP, UTP; 4 mxt ATP; 100 J.L~I each dCTP, dATP , dGTP, dTTP; 40
mxt creatine phosph at e; 100 mg/ml creatin e phosphokinase ; 15 mxt
sodium phosphat e (pH 7.5); 1 fmol of substra te DNA; and 50 J.Lg of
ext ra ct proteins. Reactions were incuba ted for 15 min at 37 °C. The
subst rate DNA was recover ed and introduced into Escherichia coli
NR9162 (mutS) via electroporation and plat ed to score plaq ues as
described (34).
MNNG Cyto toxicity-Non-con fluent cell monolayers were ha rvested
and ri nsed in severa l changes of serum-free medium, and 105 cells were
trea ted wit h eithe r 0, 1, 5, or 10 J.L ~I MNNG at 37 °C in serum-free
mediu m for 45 min . Cells were rinse d twi ce in growth medium and the n
plat ed on 100 mxi dish es at concentratio ns of 102 , 103 , and 10" cellsl
plat e. After 10 days, cell colonies were fixed with meth ano l and stained
with Giemsa, and colonies with 50 or more cells wer e counted . The
re lative surv iving fracti on was expressed as a ra tio of the plating
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Flc;.2. Mic rosate llite analysi s a t a CTI' repea t. a , analys is of
single cell HEC -I-A clones . Th e lane marked C represents the clonal
population of cells from whi ch th e sing le cell clones were genera ted. b,
analysi s of sing le cell KLE clones.
published hPMS2 gen e seque nce (29).
Microsatellite Instability in HE C·/·A Cells-We next exa m-
ined HE C-I-A cells for the microsa tell it e instability character -
isti c of tumor cell lines having mutations in th e hMSH2 and
hMLH l genes (16, 17). Single cell clones were generated from
clonal populations of HEC -I-A cells and from KLE , an endo-
metrial carcinoma cell lin e that had no detectable hPMS2 mu-
tation (see above) and was proficient in mismatch repair (see
below). When th e clones of each line reached 18 -25 population
doublings, ONA was pr epared and a na lyzed for variations a t
se veral microsatellite seque nces using the PCR. Microsatellites
were highly un stable in HE C-I-A clones. An exa mple of (CTT )"
repeat (0 7s1794) instability is shown in Fig . 2a. Eighteen of 40
single cell clones exhibited new bands, rep resenting both ex-
pansion s and contractions. Instabilit y was noted in 3 of 40
clones for 02s147 (CA)", 3 of 40 clones for 014s76 (CA)", 17 of
40 clones for 014s73 (CA)", and 2 of 40 for vWFa (TCTA)" (data
not shown). Thus, a lt hough the degree of fluctuation va ried
dependi ng on the marker used , all microsatellites examined
had at least one example of an alter ed allele. As expected of a
mismatch repair -profici ent cell line, no variations in microsat-
ellite sequences were present in 29 KLE clones examined (see
Fig . 2b for 07s 1794, data not shown for 02s 147, 01 4s76, and
014s73, vWA not examined).
Analysis of Mismatch Repair-To determine ifHEC-I-A cells
are deficient in mismatch repair, cell-free extra cts were pre-
pared and tested for th eir ability to repair a variety of mis-
paired subst rates in vitro. A circular M13mp2 ONA substrate
was used , containing a covalently closed ( + l-st rand and a (-)-
st ra nd with a nick (to direct repair to this strand) located
several hundred base pairs away from th e mispair located in
th e lacZ a -complementa t ion codin g sequence. The ( + )-st rand
encodes one plaque phenotype (either colorless or blu e) whil e
th e (- l-st rand encodes th e oth er plaque phenotype . If th e un-
repa ired heteroduplex is introduced into an E. coli strain defi-
cient in methyl-directed het eroduplex repair, plaques will have
a mixed plaque phenotype on se lectiv e plates, due to expression
of both st ra nds of the heteroduplex. However, repair occurring
during incubation of the substra te in a repair-profic ient human
cell ext ract will redu ce th e percentage of mixe d plaques and
inc rease th e ra tio of the ( + i-st rand phenotype rela tive to th at
of the (- )-st ra nd phenotype, becau se the nick directs repai r to
the (- )-st rand.
As prev iously reported (17), repa ir of substrates containing
single base mismatches and one or more unpaired nucleot ides
0
'f ~ 'f 'f « ~c; c; c; u ..;-
~ ~ ~ ~
6 ~::.
Fm, 3. Mis match re pair activi ty in three cell li nes. Th e a na lysis
was performed as describ ed und er "Exp erimental Pro cedures" using th e
subst ra tes indic ated (described in Ref 17) and reactions incu bated for
15 min . Substrates designated A conta in a nick 3' to th e listed mis-
match, whil e th e one designated B conta ins a nick 5' to t he G·G mis-
match a t position 89 . Results a rc expressed as per cent repa ir deter-
min ed from counting severa l hundred plaques per va riab le.
Measurements with two of th e substrates were perform ed multiple
tim es with simi la r res ults . Repai r val ues of $ 1% are re presented as 1%.
Repair of th e (A'-) substrate in a KLE extract was not examined. All
three extracts wer e competen t for SV40 origi n-dependent DNA repl ica-
tion act ivity (e.g . see Ref. 17), demonstrating that the repai r-defective
extracts a rc not defecti ve in all DNA tra nsactions.
is readily det ected in a TK6 cell ext ract used as a positive
control (Fig. 3). An ext ract of KLE cells a lso repairs these sa me
mismatches. In contrast, an extract of HE C-I -A cells is defec-
tiv e in rep air of all subst ra tes exa mined. Thi s deficiency is
obser ved for substra te s cont aining the nick on eithe r the 3' or
5' side of th e mism atch (Fig. 3).
MNNG Cytotoxicity-Several mism atch repair-deficien t cell
lines have been shown to be resistant to th e cytotoxic effect of
treatment with MNNG (Refs. 20 -22 and reviewed in Ref. 23).
In one instanc e, sensitivity to MNNG has been resto red to a
mismatch re pair-defective, alkylation-resistant hMLH l mu-
ta nt cell line via transfer of a wild-type chromosome 3 that
restores mismatch repair activity (21). To determ ine if th e
correlation between defectiv e mismatch repair and MNNG re-
sistance holds for HEC-I-A cells containing a hPMS2 mutation,
we treated these cells with increasin g concentra tions of MNNG
(Fig. 4). MNNG concentrations up to 10 J.t ~1 were without sig-
nificant effect , whil e mismatch repair-proficien t KLE cells
were more se ns it ive.
DISCUSSlON
A defectiv e hPMS2 gene has been implica ted in th e develop-
ment of colon cancer by th e obse rvation of a mutation in one
HNPCC kindred (29). A fun ctional role for hPMS2 in mismatch
repair has previously been suggested by the close gene se-
quence homology to the yeas t mutator gene yPMS l (29) and by
complemen tation ofa mismatch re pa ir-de fective extract by two
protein s, one of which is either hPMS2 or a closely rela ted gene
product (31). The present study directly supports a role for
hPMS2 in mismatch repair by eva luating predicted phenotypes
in an endometria l carcinoma cell line containing a nonsense
codon in the hPMS2 gene. Although we cannot exclude the
presence of mutations in oth er genes in the HE C-I-A cell line,
th e protein truncation and DNA sequencing data (Fig. 1) es-
tablish that HEC-I-A cells do lack wild-type hPMS2. The pro-
tei n that is observed is shorte r and presumabl y missing 61
C-terminal amino acids. These amino acids are highly con-
served among yPMS1, hPMS1, an d hPMS2 genes (29), sugges t-
ing that they are functionally important. The evident lack of a
18186 Mismatch Repair Defect in a hPMS2 Mutant Cell Line
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2 J. 1. Risinger, unpublished observations.
FIG.4. MNNG cytotoxicity in endometrial cancer cell lines.
Relative survival ofHEe-l-A and KLE cells after a 45-min exposure to
an increasing concentration of MNNG is shown. Each point is the
average of three independent experiments.
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wild-type transcript also suggests that both copies of this gene
must be inactivated in order for the defect to be manifest. This
reduction to homozygosity is consistent with similar allelic
inactivation observed with hMLHl and hMSH2 mutations in
cell lines and primary tumors (8-10, 12, 16, 17). In the previ-
ously reported hPMS2 mutation, deletions were identified in
both alleles of an unspecified tumor arising in this kindred, one
of which was germline and the other somatic (29).
Supporting a functional role for hPMS2 in mismatch repair
is the observation that HEC-I-A cell extracts are deficient in
mismatch repair (Fig. 3). The substrates used here already
contain an incision to direct repair to the minus strand, and
repair is defective regardless of whether the nick is 3' or 5' to
the mismatch. Thus the defect is not in incision activity, but it
could be prior to incision or it may involve the excision step.
Both possibilities are consistent with the recent study suggest-
ing that hPMS2 or a related protein forms a heterodimer with
hMLHl (31). This complex has been designated hMutLa, by
analogy to the homodimeric MutL complex of E. coli, whose
function is suggested to be formation of a complex with MutS
that activates incision by MutH and then initiates excision of
nucleotides (for review, see Ref. 36).
HEC-I-A cells also exhibit the microsatellite instability char-
acteristic of mismatch repair-deficient cell lines. Instability
was noted using five different repeat sequences. The greatest
instability was seen with a (CTT)n repeat (D7s1794, Fig. 3) and
one of three (CA)n repeats examined (DI4s73). Instability was
also detected with a (TCTA)n repeat (vWFa) and two other
(CA)n repeats. The degree of instability was less with these
latter markers, just as has been seen in other mismatch repair-
defective cell lines." The instability reported here is in accord
with previous reports of microsatellite instability in mismatch
repair-defective hMSH2 and hMLHl mutant cell lines (16,17).
As has been noted previously, mismatch repair in bacteria
and humans shares a number of common mechanistic features
(reviewed in Ref. 36). Nonetheless, E. coli contains one mutL
gene while yeast and humans clearly contain two or more genes
sharing close sequence homology to mutL. These homologs
could be involved in substrate- or tissue-specific mismatch re-
pair processes. The results presented in this study directly
implicate a biochemical role for one of these homologs, hPMS2,
in the repair of mispaired and unpaired nucleotides. They also
